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Abstract
The effect of polymer coatings on the pulmonary toxicity of multi-walled carbon nanotubes
Lindsey M. Bishop
Nanotechnology is the science of developing and manipulating molecular structures
smaller than one hundred nanometers in at least one dimension. These structures are collectively
called engineered nanomaterials. A subgroup of these engineered nanomaterials are multi-walled
carbon nanotubes (MWCNT). They are of great interest to industry because of their small size,
large surface area, strength, and conductivity in comparison to materials currently used. Practical
applications of MWCNT include improvements for water filtration systems, composites, and drug
delivery. The same properties that make them advantageous for industry may also confer adverse
health effects. For workers in the U.S. handling CNTs, the process of synthesizing and handling
the dry powder form has been shown to be the greatest risk for inhalation exposure.
Companies synthesize or purchase as-produced multi-walled carbon nanotubes (AP-MW),
apply a polymer coating (PC-MW), then embed the PC-MW into a composite (e.g. thermoplastic
or fiberglass matrix). The intermediate step of polymer coating the AP-MW is for increased
dispersion in order to use less material, improve bonding to epoxy matrices for increased strength,
and better handling to reduce exposure. Workers are potentially exposed at each production stage
especially from dry powder handling of the AP-MW and PC-MW. Comprehensive toxicological
data on AP-MW and paired PC-MW remains sparse. The aim of this study was to understand the
effect of polymer coatings on the toxicity of AP-MW in vivo. Two AP-MW, with different
characteristics, were chosen for this study. Each AP-MW came from a distinct manufacturer, each
with the polymer coated version for toxicological analyses.

All materials used for the in vivo toxicological studies were comprehensively characterized
(e.g., length, width, surface area, etc.). Male C57BL/6J mice were dosed by oropharyngeal
aspiration with vehicle (physiologic dosing medium), AP-MW or PC-MW from each company at
4 µg (workplace relevant) or 40 µg (known to induce pathology) and sacrificed at 4 h, 1, 7, 28 and
84 d post-exposure. Post-exposure analyses included: bronchoalveolar lactate dehydrogenase
activity (cytotoxicity), cell influx (inflammation) and inflammatory proteins, and relative mRNA
expression in pulmonary tissue. Qualitative pathological endpoints such as granuloma formation
and fibrosis were examined in conjunction with pulmonary biodistribution primarily to address
differences due to the polymer coating. Both AP-MW induced time- and dose-dependent measures
of pulmonary cytotoxicity, inflammatory cell influx, and inflammatory proteins that resolved by
84 d post-exposure. The PC-MW from Company 1 had no additional effect on induced pulmonary
cytotoxicity, inflammatory cell influx, or inflammatory gene expression and inflammatory protein
production as compared to the respective AP-MW. However, pulmonary cytotoxicity,
inflammatory cell and inflammatory protein production were attenuated in the PC-MW exposed
groups from Company 2 in comparison to the respective AP-MW. Based on qualitative
observations of AP-MW and PC-MW from Company 1, particles deposited mostly within the
bronchioles, were generally cleared by 84 d while a small portion was persistent in alveolar
regions. There was no difference in histopathology with respect to the materials compared from
Company 1. Similar distribution of particle deposition in lung compartments was observed for APMW and PC-MW exposed groups from Company 2, however a larger fraction deposited into
alveolar regions. Small granulomas were observed in the bronchioles of AP-MW exposed groups
from Company 2. In contrast, granuloma formation was absent in the PC-MW exposed groups
with slightly more particle aggregation. In conclusion, the two polymer coatings studied did not

increase the pulmonary toxicity compared to the AP-MW. In fact, inflammation and
histopathology was attenuated in mice exposed to the polymer coating from Company 2. It is
evident that pulmonary toxicity, from AP-MW to PC-MW, must be carefully considered within
the occupational setting.
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2.0 Introduction
2.1 Nanotechnology and carbon nanotubes
Nanotechnology is the science of developing and manipulating molecular structures, called
engineered nanomaterials, which are smaller than one hundred nanometers in at least one
dimension for use in macroscale products (Donaldson et al., 2006). Within the last two decades,
nanotechnology has become a major research and manufacturing field for the creation of stronger
materials, longer-lasting fabrics and scratch resistant plastics for use in industrial and consumer
sectors. Practical applications for nanotechnology have tremendous potential in consumer based
products. These include water filtration systems, sunscreens, electronic microprocessors, and
thermoplastics (Thostenson et al., 2002; Liu et al., 2005; Xiong et al., 2006). The benefits of

incorporating engineered nanomaterials into composites allow manufacturers to tailor the
molecular structure of these materials to achieve specific chemical properties for functionally
distinct products. For example, the final product of an item reinforced with nanomaterials can be
stronger, more reactive, or improve electrical conductivity (Martins et al., 2013). To date, over
eight hundred commercial products rely on nanoscale materials and processes.
The carbon-based engineered nanomaterials are some of the most widely utilized for
market applications. As their name suggests, carbon nanomaterials are composed of carbon with
varying metal impurities, as a result of their formation and synthesis. Most carbon nanomaterials
take the form of spheres or tubes. Spherical carbon nanomaterials are referred to as fullerenes,
which were discovered by Robert Curl Jr., Harold Kroto and Richard Smalley (Liu et al., 1998).
These individuals won a Nobel Prize in Chemistry in 1996 for their discovery of fullerenes (Royal
Swedish Academy of Sciences, 1996). In the same type of process that formed fullerenes, Sumio
Iijima discovered cylindrical concentric tubes, which today are referred to as multi-walled carbon
nanotubes (MWCNT). A short time later, Iijima took the information about MWCNT and isolated
1

single walled carbon nanotubes (SWCNT) in the presence of a metal catalyst. SWCNT are hollow
tubes composed of a single layer of carbon with diameters around one nanometer (Yudasakaet al.,
1997; DeVolder et al., 2013). The formation of SWCNT is favored when the metal nanoparticlesto-carbon ratio are high, whereas, MWCNT can be formed with minimal amounts of metal catalyst,
these catalysts act to align the nanotubes for further downstream applications (Zhang et al., 1999).
However, the metal impurities utilized for the formation of SWCNT and MWCNT are generally
unfavorable in commercial products (Baughman et al., 2002). For this reason, large batches of
CNT are sold in purified forms, with metal contaminants removed. Once formed, both SWCNT
and MWCNT have an incredible propensity to agglomerate. This is due to intrinsic van der Waals
forces, and high hydrophobicity. Because these materials agglomerate easily, they are often
incorporated into liquid medium for increased dispersion (Donaldson et al., 2006; Porter et al.,
2008). An increase in dispersion for industrial purposes provides a more homogenous mixture for
a stronger and durable end product. Without adequate dispersion techniques, an agglomerated
heterogeneous blend could lead to a fragile product.
As shown in Figure 1, SWCNT become agglomerated tangles in liquid medium. SWCNT
appear as very thin fibers having diameters of about one nanometer and being several micrometers
long, which results in their high aspect ratio (length/diameter) (Donaldson et al., 2006; Ajayan et
al., 1997). Rarely do SWCNT exist as individual tubes but rather as bundles. From a market
perspective, SWCNT only make up a small subset of carbon-based nanomaterials (Future Markets
Inc., January 2016). It is the larger MWCNT that dominate the current CNT market. In contrast to
SWCNT, MWCNT have additional concentric layers with much larger diameters between five and
two hundred nanometers (Donaldson et al., 2006; Oberdorster et al., 2016). In addition, the lengths
of MWCNT can be much longer than that of SWCNT. MWCNT have weaker van der Waals forces
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and can exist as single tubes and form fewer bundles, especially with increasing diameters as seen
in Figure 1 (Yu et al., 2000).

Figure 1: Representative transmission electron microscopy pictures of
SWCNT (left panel) and MWCNT (right panel) preparations in
dispersion media (Erdely et al., 2009).
2.2 SWCNT-induced pulmonary effects
While industry saw the potential for numerous applications, there was uncertainty about
how CNT would affect biological systems. Initial field studies indicated that inhalation was the
most likely route of exposure for individuals working with the dry powder form of CNT (Dahm et
al., 2011). The dry powder exhibit a lower density. Therefore, it aerosolizes with ease and has the
ability for deposition into the airways within the lungs (Muhlfeld et al., 2012). The pulmonary
system is a highly branched network of tubules which culminate into a complex web of vascular
alveoli. These alveoli are specialized for providing a large surface area in the lung for gas exchange
of oxygen and carbon dioxide. Small inhaled particles, such as CNT, can travel through this
network and into alveolar regions and may impede the efficiency of gas exchange, whereas larger
particulates deposit within upper airways of the primary bronchi, and generally are cleared
(Oberdörster et al., 2005; Simeonova et al., 2009). Normally, in these alveolar regions, particles

3

are blocked from entry into the systemic circulation by a plethora of host defenses. These defense
mechanisms can range from a protective epithelial cell lining, to resident phagocytic cells, to the
surfactant layer. Particle exposures are known to induce tissue injury and potentially affect
pulmonary function (Deng et al., 2005; Bergamaschi et al., 2006; Simeonova et al., 2009). Because
of their physicochemical characteristics, it was suspected that CNT would have the ability to
induce pulmonary damage in vivo.
The initial studies to evaluate the toxicity of CNT were performed using SWCNT (Lam et
al., 2004; Warheit et al., 2004; Shvedova et al., 2005; Mangum et al., 2006). In 2004, Lam et al.,
intratracheally instilled mice with SWCNT and found that exposure to these materials induced
dose-dependent epithelioid granulomas, and in some cases interstitial inflammation 7 d postexposure. They concluded that if SWCNT reached the lungs, these induced toxicities can be
considered an occupational health hazard if chronically inhaled (Lam et al., 2004). Shvedova et al.
(2005) introduced a large bolus dose (10-80 µg) of SWCNT by pharyngeal aspiration in mice. In
this technique, a dose of material is deposited into both the conducting and respiratory zone of the
lung, while the animal is under light anesthesia and breathing normally. Following exposure, this
group described an inflammatory and granulatomas response at sites of SWCNT agglomerate
deposition in the distal bronchial and proximal alveoli. In addition, exposed mice showed signs of
interstitial fibrosis 7 days post-exposure in the lung parenchyma, concluding that these nanotubes
translocated to distal alveolar septa (Shvedova et al., 2005). Most of the scientific community
agreed that pulmonary exposures to SWCNT induced varying degrees of inflammation, granuloma
formation and interstitial fibrosis (Lam et al., 2004; Warheit et al., 2004; Shvedova et al., 2005)
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2.3 SWCNT induces cardiovascular and systemic toxicities
In addition to SWCNT impacting the pulmonary tissue, a group of researchers studied the
cardiovascular toxicity and systemic translocation of SWCNT following pulmonary exposure. Li
et al. (2007) showed that pulmonary toxicity of SWCNT following respiratory exposure could be
correlated with systemic toxicities. They were able to demonstrate a dose-dependent increase in
vascular oxidative damage and mitochondrial dysfunction (Li et al., 2007). Furthermore, they
found that mice exposed to SWCNT developed aortic mitochondrial DNA damage over 60 days
post-exposure, lending support that respiratory exposure to SWCNT may exert prolonged adverse
health effects. Mitochondrial dysfunction has been used as a factor to link a number of
cardiovascular diseases, including atherosclerosis (Li et al., 2007; Simeonova et al., 2009). With
the onset and progression of atherosclerosis, inflammatory cells are recruited to sites of insult by
activated platelets. This in turn recruits leukocytes to the site of damage to clear debris and begin
repair mechanisms. Pulmonary exposures to SWCNT induced platelet activation, and exacerbated
atherosclerotic lesion formation, in vivo (Simeonova et al., 2009; Li et al., 2007). Erdely et al.
(2009) explained that a chronic systemic response to pulmonary exposures of SWCNT can
exacerbate cardiovascular dysfunction. This group established that respiratory exposure to
SWCNT caused the development of a unique blood gene and protein signature, which confirmed
the intricate occurrence of cross-talk between the pulmonary and systemic circulations following
exposure (Erdely et al., 2009). Overall, the in vivo experiments detailing the adverse effects of
pulmonary exposure to SWCNT were vital when assessing the potential health impact on a larger
scale, such as the workers who may be at risk for inhaling CNT.
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2.4 MWCNT-induced pulmonary effects
Over the years, our knowledge of the pulmonary and systemic exposures to SWCNT has
led scientists to investigate the impact of MWCNT on pulmonary toxicity, seeing that this material
dominates the current consumer market. In 2008, researchers at the University of Edinburgh
described inflammation and formation of granulomas, in the mesothelial lining of the chest cavity
in mice following intrapleural instillation of MWCNT (Poland et al., 2008). In addition, Muller et
al. (2005) administered a bolus dose of MWCNT (unprocessed and ground material) to SpragueDawley rat lungs by intratracheal instillation. This group reported that 60 days post-exposure,
pulmonary tissue had significant increases in inflammation, granulomas and fibrosis compared to
control. In those exposures, the ground form of MWCNT were more dispersed in alveolar regions
and induction of granulomas was observed with additional particle laden macrophages, similar to
results reported for SWCNT (Lam et al., 2004; Shvedova et al., 2005; Warheit et al., 2004). Porter
et al., (2010) showed that an aspiration of dispersed MWCNT caused time-and dose-dependent
responses of granuloma formation and pulmonary fibrosis. Mercer et al. (2011) reported
penetration of MWCNT through alveolar epithelial cells into the alveolar interstitial space after
pharyngeal aspiration of dispersed MWCNT in mice. These findings suggested the need to
evaluate chronic toxicity of MWCNT at sites within the deep lung.
Concerns of occupational exposures have arisen due to the understanding that adverse
effects occur from MWCNT lung deposition which were observed during animal studies in
previous years (Muller et al., 2005; Simeonova et al., 2009; Mangum et al., 2006; Li et al., 2007;
Mercer et al., 2008; Porter et al., 2010; Sager et al., 2014). The results from an inhalation study
conducted by Ma-Hock showed that inhaled MWCNT produced lesions in the lung and stressed
the need to compare various MWCNT toxicities. Selection of MWCNT with the lowest risk for
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applications would reduce the potential risk of inhalation exposure to humans (Ma Hock et al.,
2009). A repeated 13-week inhalation study with male and female rats exposed to MWCNT
showed particle laden alveolar macrophages, increased inflammatory cells and interstitial fibrosis
(Pauluhn et al., 2010). Both of these exposure studies were essential for the development of a
recommended exposure limit (REL) in order to protect and prevent lung injury to workers handling
these types of MWCNT (Pauluhn et al., 2010; Ma-Hock et al., 2009; NIOSH CIB 65).
2.5 MWCNT induces cardiovascular and systemic toxicities
The nanotoxicology community began to recognize that pulmonary exposures to MWCNT
have a unique impact on systemic toxicity. It has been shown that inhalation exposures to MWCNT
suppressed immune function in mice. Suppression occurred through the activation of signals,
beginning at the pulmonary tissue and ending with the activation of signals in the spleen (Mitchell
et al., 2007, 2009). MWCNT exposures have led to serum increases of pro-inflammatory cytokines
such as, interleukin-6 (Il-6), and the neutrophil chemoattractant, chemokine (C-X-C) ligand 1
(Cxcl1). Increased serum inflammatory proteins were a result of pulmonary exposure to MWCNT,
which suggested a corresponding response by systemic tissue. This was verified by increased gene
expression of Il-6 in aortic tissue (Erdely et al., 2009). These studies demonstrated a close intersect
between the pulmonary and systemic circulation following exposures to MWCNT. Oropharyngeal
aspiration in MWCNT to mice promoted susceptibility of cardiac tissue to ischemia/reperfusion
injury without a pulmonary inflammatory response, suggesting a risk to the cardiovascular system
in the presence of MWCNT (Urankar et al., 2012). Another study evaluated arteriolar reactivity in
response to MWCNT inhalation. Results indicated that MWCNT inhalation leads to impairments
of endothelium-dependent dilation in coronary microcirculation at 24 h post-exposure (Stapleton
et al., 2012).
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Pulmonary exposures to MWCNT requires complex evaluations of cardiovascular
toxicity, regardless of rodent model (Erdely et al., 2009; Stapleton et al., 2012). A long term
assessment of systemic toxicity was conducted in 2009 with Wistar rats. This 90-day inhalation
toxicity study concluded that inhalation exposure to MWCNT produced no systemic toxicity while
minimal multifocal granulomas and neutrophilic inflammation was observed in lung tissue (MaHock et al., 2009). In 2010, a study conducted by Jurgen Pauluhn reported that extrapulmonary
translocation or systemic toxicity was absent in any biological specimens.
2.6 Post-processing MWCNT
As discussed, numerous toxicological studies have demonstrated the potential health
implications following pulmonary exposures to MWCNT in vivo (Shvedova et al., 2005; Mercer
et al., 2011;Mercer et al 2013a, 2013b; Erdely et al., 2009, 2013). Continued research has
discovered that alterations to the physicochemical properties of CNT can lead to dramatically
different ranges of functional end products (Kong et al., 2004; Vaisman et al., 2006; Sahoo et al.,
2010; Martins et al., 2013). Post-processing MWCNT allows manufacturers to tailor large
quantities of MWCNT for specific use. Post-manufacturing processes include, and are not limited
to, acid washing, functionalization or polymer coating (Liu et al., 2005; Xiong et al., 2006; Wang
et al., 2009). Velasco-Santos (2003) explained that functionalized carbon nanotubes bonded to a
polymer matrix, exhibited enhanced the mechanical properties of a thermoplastic product.
Functionalization can include, nitrogen doping, amination and esterification of the carboxylic
groups bound to the surface of CNT (Li et al., 2013). An inverse relationship exists between
particle size and surface expressed molecules as a result of functionalization. Importantly, the
number of atoms or molecules attached to the surface of MWCNT may determine material
reactivity in biological tissue (Nel et al., 2006; Sager et al., 2014). A study in 2013 assessed
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covalently functionalized MWCNT to assess the impact of surface charge in a toxicological model
for pulmonary fibrosis. The results demonstrated that surface charge is an important predictor of
the pro-fibrotic potential of functionalized MWCNT in the lung, with highly negative MWCNT
being less toxic and highly positive MWCNT being more toxic (Nel et al., 2009, 2013). Overall,
post-processing results in dramatically different sizes, shapes, and chemical compositions of
MWCNT, many of which, have unknown toxicities when compared to the AP-MW in vivo.
2.7 Polymer-coated MWCNT
The abundance of research involving CNT and their impact on pulmonary and systemic
health effects has focused mainly on AP-MW and is well known (Oberdorster et al., 2016
Bergamaschi et al., 2006; Borm et al., 2004; Donaldson et al., 2002, 2006). A recent advancement
in the life cycle of MWCNT manufacturing involves polymer-coating MWCNT (PC-MW) for
numerous reasons, some of which include increased dispersion into composites, ease in handling
and reduced dustiness without affecting the properties of the native MWCNT (Liu et al., 2005;
Xiong et al., 2006;). What remains unknown is the pulmonary toxicity of PC-MW from U.S.
manufacturing companies in comparison to their AP-MW.
The French Institute of Health and Medical Research (INSERM) investigated the toxicity
of MWCNT coated with a polystyrene polybutadiene polymethylacrylate (PMMA) polymer.
Coating MWCNT with PMMA did not affect the intrinsic properties of the MWCNT and
decreased cytotoxicity, inflammation and oxidative stress in vitro and in vivo (Tabet et al., 2011).
Though this group found that a PMMA polymer-coated MWCNT reduced toxicity, it remains
unclear if other types of polymer coatings affect toxicity of MWCNT in vivo. To more thoroughly
understand the impact of polymer coatings on the pulmonary toxicity of MWCNT, the current
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project utilized two PC-MW which are currently being handled in the U.S., and assessed the
toxicity of these materials compared to their associated AP-MW counterpart.
2.8 CNT and potential human health implications
The U.S. National Science Foundation predicted that a large increase in workers would be
needed to support the growing field of nanotechnology. They urged the importance of
toxicological evaluation of nanoparticles before any adverse health consequences could arise as a
result of handling these materials. Despite the toxicity findings to date regarding CNT, even the
most modest predictions show continued growth of the industry through 2025 (Future Markets
Inc., January 2016).
NIOSH issued a current intelligence bulletin (CIBs) that summarized toxicity research to
date regarding occupational hazards of CNT. In this document, NIOSH reviewed short-term and
sub-chronic animal studies involving CNT exposures, which resulted in early stage fibrotic and
inflammatory lung responses. This compilation of studies was used to establish a recommended
exposure limit (REL) for individuals handling these materials. NIOSH proposed a recommended
exposure limit (REL) of 1 µg/m3 of elemental carbon as a respirable mass, based on an 8-hour
time-weighted average (TWA) concentration. The proposed REL is a recommendation used to
minimize the risk for pulmonary inflammation and fibrosis to workers handling CNT over a life
time of exposure, or 45 working years (NIOSH CIB 65). Researchers at NIOSH used this
recommendation when extrapolating the data from workplace exposures for the design of an in
vivo inhalation study (Erdely et al., 2013). This inhalation study exposed mice to similar levels of
MWCNT, based on extrapolations from exposure assessments of U.S-based CNT facilities. Their
findings showed limited pulmonary inflammatory potential of MWCNT at exposures reported in
US worksites evaluated by NIOSH, and their estimates suggested a considerable amount of
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working years (about 76) would be needed to induce significant pathology (Erdely et al., 2013).
Since the proposed REL was established, an industrywide exposure assessment study was
conducted to assess occupational exposures to CNT. Of the fourteen total sites visited within the
study, epidemiologists concluded that all worker exposure samples, based on personal breathing
zone measurements, were below the NIOSH REL for the respirable fraction (Dahm et al., 2015).
It is important to understand the interactions of CNT and their impact on pulmonary
toxicity in rodents in order to generate data that can be used for risk assessment (Oberdorster et
al., 2015). Our understanding of the toxicological impact can be used to develop predictive
screening standards at loccupational levels. To achieve this goal, toxicologists must utilize
exposure assessment studies in order to design in vivo protocols where results accurately reflect
current worker exposures within the U.S. (Xia et al., 2009; Liou et al., 2015).
3.0 Study AIM
The overall objective of the current study was to evaluate and describe the toxicological
impact of two different AP-MW and their PC-MW counterparts in vivo. Based on previous animal
studies, it is critical to understand how these materials impact occupational health. To date, little
is known about the toxicities associated with PC-MW, most of which make their way into
composite manufacturing for consumer products. Furthermore, research regarding the toxicities of
these nanoenabled composites is sparse. Ongoing exposure assessment studies from U.S. CNT
manufacturing facilities were vital to this research as a way to bridge the gap between occupational
exposure assessments and in vivo animal studies. The research presented here, utilizes the same
AP-MW and PC-MW currently handled in U.S. facilities which have participated in NIOSH field
assessments.
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This study focused on the combination of AP-MW and PC-MW from two separate
companies (Figure 2). Each company had separate intentions for utilizing polymer coatings.
Company 1, synthesizes their own branched AP-MW and uses an off the shelf polyurethane
coating. This company wanted to reduce dustiness of the AP-MW in order for ease of handling
and involuntary product loss downstream, as this material aerosolizes easily. Additionally, they
use polyurethane to increase dispersion of MWCNT in liquid medium to improve thermoplastic
manufacture. Conversely, Company 2 purchases a bulk supply of AP-MW, and coats this material
with a proprietary poly(arylene ethynylene) (PAE) polymer (Figure 2). Company 2 utilizes this
polymer to increase dispersion and adhesion to an epoxy matrix which will be used in the
manufacture of composites.

Company 1

Company 2

AP-MW: In house
synthesis

AP-MW: Bulk purchase

PC-MW: Polyurethane

PC-MW: Proprietary
PAE

Figure 2: AP-MW and PC-MW material overview. Each U.S. based company adopts
different methods for polymer coating. This study focused on the pulmonary toxicity
following the addition of an off the shelf polyurethane or proprietary polymer to AP-MW
in vivo.
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4.0 Methods
The general experimental approach to assess pulmonary toxicity in vivo, to both AP-MW
and PC-MW is shown in Figure 3. The hypothesis was that PC-MW would alter toxicity in
comparison to AP-MW in vivo. Time-and dose-dependent responses were assessed along with
potential pathological outcomes following exposures. Each chapter herein describes the molecular
and pathological effects of these pairs of AP-MW and PC-MW following oropharyngeal aspiration
in a mouse model.

CytotoxicityLactate
dehydrogenase
(LDH)
Bronchoalveolar
lavage (BAL)
Inflammatory
proteins and cells
Post-Exposure
harvest: 4 hr, 1, 7,
28, 84 d

Histopathology

Particle distribution

Pulmonary tissue
collection

Relative mRNA
expression

Figure 3: Endpoint analyses following exposure to either AP-MW or PC-MW. Analyses include:
analysis of BAL for cytotoxicity as measured by LDH, pulmonary inflammatory cell influx and
protein abundance, and quantitative measurement of relative mRNA expression of pulmonary
tissue.
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4.1 Exposure Assessment
Ongoing research has suggested that occupational exposure to CNT could result in a variety
of adverse health effects. To address this concern, Dahm et al. (2015) conducted an industry wide
exposure assessment study of CNT primary and secondary manufacturers. To assess worker
exposure, this group utilized personal breathing zone (PBZ) samples. Briefly, PBZ samplers are
attached to the collar of a worker, throughout normal working hours. Following each shift, PBZ
samples were collected for analysis of elemental carbon at inhalable and respirable sized fractions
by transmission electron microscopy. These fractions are assessed to understand the percentage of
particles that can be inhaled, as well as the fraction that has the potential to reach deep within the
lungs (respirable). Until more information is available about the effects of CNT on occupational
health, PBZ elemental carbon (EC) samples are a way to limit potential health risk and to assess
worker exposure at both the inhalable and respirable sized fractions (Dahm et al., 2015). Fractions
of material that have the potential to reach larger airways and persist are known as inhalable, while
respirable sized fractions have the potential to travel deeper within the lung. The representative
electron microscopy images of PBZ samples collected from both workplaces that handle the
materials tested for this study were evaluated (Figure 5 and 19). The PBZ TEM images for this
study were used in order to determine proper dosing methodology for adaptation in a rodent model.
4.2 Characterization
Scanning transmission electron microscopy (STEM) images were obtained for all materials
from Company 1 and 2 using an S-5500 ultrahigh resolution SEM with STEM capabilities (RJ Lee
Group, Inc., United States). Length and diameter for each material was calculated based on an
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average of n=200 nanotubes. All measurements for zeta potential, an indicator of surface charge
in the dosing medium, were performed using a Nano ZS90 instrument (Malvern Instruments, UK).
Viscosity of control medium was previously determined at room temperature using a VS-10
viscometer (Malvern Instruments) and used as the value for calculation of zeta potential. The
agglomeration state of MWCNT can be different for each material depending on the structural
arrangement of carbon atoms and their interaction with surrounding ions, in solution. Riddick
(1968) used zeta potential to develop categories that describe the stability of these dispersions in
liquid media. Essentially, a weak electrical force (-12mV) will allow the material to agglomerate,
because the particles do not have enough surface charge to repel each other. Normally, a dispersion
with a large electrical force (-61 to -80 mV) allows particles to remain suspended in liquid, or have
high stability. X-ray photoelectron spectroscopy (XPS) was utilized to measure the elemental
surface chemistry of each sample. In addition, hydrodynamic diameter was measured by dynamic
light scattering (DLS). DLS characterizes nanoparticles by measuring the fluctuations in the
scattering intensity of a solution over time (Ansell et al., 2011). The measured hydrodynamic
diameter is a value to explain how a particle diffuses within a fluid, in this case, the physiologic
medium for in vivo exposures. The hydrodynamic diameter represents the particle size of spherical
structures once in the physiologic medium. Although this method is not optimal for fibrous
structures, it can be used to qualitatively infer the degree of agglomeration of CNT. The endotoxin
contamination was measured using the Limulus Amebocyte Lysate test. Metal content was
measured by inductively coupled plasma atomic emission spectroscopy (ICP-AES).
4.3 Study design and particle aspiration
Male C57BL/6J pathogen-free mice weighing 20-25g were obtained from Jackson
Laboratories, Bar Harbor, ME. All mice were housed in the assessment and accreditation of
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laboratory animal care (AAALAC)-accredited NIOSH Animal Facility and afforded food and tap
water ad libitum in ventilated cages, on autoclaved hardwood chip bedding in laminar flow cages
and an environment of controlled humidity and temperature. This environment was equipped with
12 hours of light/dark cycles per day. Animals were allowed to acclimate for at least seven days
prior to use in any experiments. Animal care and use procedures were conducted in accordance
with the “PHS Policy on Humane Care and Use of Laboratory Animals” and the “Guide for the
Care and Use of Laboratory Animals” (NIH publication 86-23, 1996). The procedures utilized in
this study were approved by the National Institute for Occupational Safety and Health Institutional
Animal Care and Use Committee.
Male C57LB/6J mice, eight to ten weeks of age, were exposed by oropharyngeal aspiration
to either vehicle control or selected MWCNT at two different concentrations, 4 or 40 µg per mouse
dependent on study design (Figure 4). Physiologic medium, the vehicle, was prepared fresh each
morning and contained mouse serum albumin (0.6 mg/ml) and pulmonary surfactant (10 µg/ml; 1,
2-Dipalmitoyl-sn-glycero-3-phosphocholine, DPPC; Sigma Life Science) prepared in United
States pharmacopeia (USP) grade-phosphate buffered saline (PBS) without calcium and
magnesium. Low (4 µg) and high (40 µg) dose concentrations were chosen from previous studies
in order to mimic workplace exposures. The lowest dose was chosen to accurately reflect relevant
human exposure levels as reported by Erdely et al. (2013). The low dose is equivalent to 7.6
working years, a time point representative of the years in operation of these studied facilities within
the U.S., while the highest dose (40 µg) will elicit pathology within a short time frame (84 d)
(Erdely et al., 2013). According to the manufacturers, the polymer coatings are 7 and 15% of the
total weight from Company 1 and Company 2, respectively. Extrapolations were made in order to
account for the weight of the coating, which was then dispersed in the liquid medium for control
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dosing purposes. Each dry AP-MW and PC-MW was weighed equally by mass. Each AP-MW
had a final concentration of 1.6 mg/mL in physiologic dosing medium while the PC-MW samples
were suspended in 850 or 930 µl of physiologic dosing medium (Company 1 and Company 2
respectively). Thus, the mass of MWCNT in each sample, regardless of coating, remained similar.

Vehicle

Physiologic
dosing
medium
4 µg

C57BL/6J
(8 - 10
weeks)

AP- MW

40 µg
4 µg

PC-MW
40 µg
Figure 4: Experimental Design. Two sets of mice were used for each company, one for
histopathology as well as pulmonary and systemic tissue gene expression and a second set
for analyses of BAL samples to determine inflammatory cell influx and cytotoxicity.
Each mouse was anesthetized in a bell jar containing a tissue-tek mega-cassette (Sakura)
packed with gauze, which was moistened with USP grade isoflurane (0.5 mL) (Piramal Healthcare,
Andhra Pradesh, India). When fully anesthetized, as noted with unsteady gate, decreased mobility
and tail drop, the mouse was taken out of the bell jar and placed on a slant board (Saffiotti et al.,
1968; Rao et al., 2011). The animal was positioned in such a way that its back, neck and cranium
rests on the board. The mouth was gently opened to suspend the mouse by its incisor teeth along
a thin braided cord. The tongue was pulled aside and extended away from the oral cavity by small
forceps. A fifty microliter suspension of dosing medium was pipetted at the base of the tongue,
while tongue restraint continued for five normal breaths to inhale the droplet. Once all the exposure
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solution was aspirated by normal respiration, the tongue was released and the mouse was lifted
from the board, and placed back into the housing unit. Each mouse was observed for a short time
following this procedure to ensure full recovery from anesthesia. At 0 (4 hours), 1, 7, 28 and 84 d
post-exposure, mice were euthanized for evaluations of pulmonary responses using two sets of
mice for each company. The first set of mice was used to determine molecular parameters,
pulmonary inflammatory cell influx and cytotoxicity using bronchoalveolar lavage fluid (BALF).
In the second set of mice, right lung lobes were fixed and embedded in paraffin wax, and sectioned
for determination of lung burden of MWCNT and histopathology. The left lung lobe was ligated
and frozen in liquid nitrogen for relative mRNA expression.
4.4 Bronchoalveolar lavage (BAL):
Mice were anesthetized with an i.p. injection of sodium pentobarbital (100mg/kg body
weight) at 4 hr, 1, 7, 28 and 84 d post-exposure. Whole blood was collected from the inferior vena
cava and saved for later analysis. Following euthanization by exsanguination, BAL was performed
by cannulating the trachea and lavaging the lungs with physiological saline, first at 0.6 mL and
two subsequent lavages at 1.0 mL for a total of 2.6 mL of BAL fluid (BALF). Lavage collections
were centrifuged for acellular and cellular fractions. The acellular fraction (< 0.6 ml) of the first
lavage was kept separate for BALF inflammatory protein analysis (Myriad/ RBM; Austin, TX) by
multiplex immunoassay RodentMAP v3.1. The acellular BALF fraction was also used to
determine the cytotoxicity of MWCNT as measured by lactate dehydrogenase activity (LDH).
Lactate dehydrogenase is a cytoplasmic enzyme present in most cells. A rupture of the cell
membrane can cause cellular contents, including LDH, to be released to the surrounding fluid.
Therefore, measuring LDH activity is an indicator of cell damage following MWCNT exposure in
vivo. The Cobus 400 analyzer series (Roche Diagnostics, North America) quantitatively
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determines the catalytic activity of LDH in non-frozen samples by measuring the reduction of
pyruvate to form L-lactate in the presence of NADH.
The cellular BALF fractions from both the first and second lavage were combined in a total
of 800 µL of USP grade PBS. Total cell number was measured using a hemocytometer. A
hemocytometer is a chamber, that when loaded, allows an individual to tally the number of cells
in a precise volume of fluid. Using this method, the concentration of cells in the total fluid was
calculated to determine the total number of cells harvested by BAL. The reconstituted cellular
fraction of the BALF was loaded into funnels for the Thermoscientific Cytospin 4 (FisherbrandColorfrost Plus Microscope Slides-Precleaned) and spun (800 g for 5 min) onto slides.
Differentials from the cellular fraction were made from counts of 300 cells per slide following
staining by a modified Wright-Giemsa stain. Cells were identified as neutrophils, eosinophils,
lymphocytes and macrophages. The number of each tell type was determined as the percent cell
type multiplied by the total number of cells. Pulmonary inflammation is indicated by an elevation
in neutrophils harvested by BAL.
4.5 Pulmonary gene expression
Lung tissues were dissected and immediately frozen in liquid nitrogen. All samples were
stored at -80° C prior to analysis. RNA was isolated from pulmonary tissue using the RNeasy Mini
Kit (Qiagen, Valencia, CA, USA). Pulmonary gene expression was determined by standard 96well technology using the StepOne Plus (Applied Biosystems, Carlsbad, CA, USA) with predesigned Assays-on-Demand TaqMan probes and primers including Il-6 (Mm00446190_m1),
Ccl22 (Mm00436439_m1), Cxcl2 (Mm00436450_m1), Ccl2 (Mm00441242_m1), and Spp1
(Mm00436767_m1) (Applied Biosystems). Using 96 well plates, RNA (1 µg) was reverse
transcribed using random hexamers (Applied Biosystems) and Superscript III (Invitrogen,
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Carlsbad, CA, USA). Dilute cDNA (1/10) was used for gene expression determination.
Hypoxanthine-guanine phosphoribosyltranferase (HPRT) was used as the endogenous reference.
Relative gene expression was calculated using the comparative threshold method (2-ΔΔCt) with
vehicle-treated mice serving as the reference group (Schmittgen et al., 2008).
4.6 Particle distribution
To understand particle deposition following exposure, one hematoxylin and eosin (H&E)
stained section of lung was examined at 10X magnification. Based on the relative amount of
particle/size of the deposit (small, medium, large and extra-large) each focused deposition was
scored individually from 1-4. Minimal depositions or small deposits were scored with a one. This
included small clusters of particle-laden macrophages, or particularly small extracellular deposits
of particles. Individual alveolar macrophages containing particles were difficult to view at low
magnification. Scores incrementally increased with increasing deposition; a score of four included
extensive deposition or extremely large deposits. This score included airways with entangled
particles or extracellular aggregates. This score does not account for plugged airways in each
sample. To normalize the data and compensate for different amounts of aspired particles, burden
in each lung region was expressed as a percent of the total lung burden. Percent of particle burden
was tabulated for bronchioles, terminal bronchioles, alveolar ducts and alveolus. By choosing to
represent particle burden as a percent of the total lung burden, it is easy to make comparisons
between lung regions and understand location of particle distribution following exposure.
4.7 Histopathology
Mice were euthanized and the left lung lobe was excised and frozen, while the remaining
right lung lobes were inflated with 10% buffered formalin. Following fixation, right lung sections
were cut, stained with H&E and interpreted by a board certified veterinary pathologist, who was
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blinded with respect to treatment group. Presented in this thesis are initial qualitative observations
of histopathology with respect to AP-MW vs PC-MW. The pulmonary pathology that MWCNT
can induce in vivo is well-established, the particular goal was to report any unique observations of
effect due to polymer coatings. Quantitative measures of inflammation, granuloma formation, and
fibrosis are in process.
4.8 CytoViva hyperspectral imaging
CytoViva technology integrates enhanced darkfield-based microscopy with high resolution
hyperspectral imaging. Sirius Red staining consists of immersing slides in 0.1% picosirius
solution, the left lung tissue stained with Sirius Red were mounted and cover slipped for use in the
dark field imaging. This unique preparation helps distinguish MWCNT from normal tissue.
Nanoparticles within the lung sections were imaged using a darkfield-based illumination on an
Olympus BX-41 microscope (CytoViva, Auburn, AL) at 100X oil immersion. The combination of
the CytoViva hyperspectral imaging and CytoViva microscope system has been used previously
to quantify the presence of MWCNT in tissues (Mercer et al., 2013). Staining of extracellular
matrix components helps to understand tissue remodeling and connective tissue pathologies
(Mercer et al. 2011, Lattouf et al., 2014). This technique enhances the contrast between biological
tissue and MWCNT (Mercer et al., 2011). Carbon nanotubes have properties that allow them to
scatter light very differently than biologic tissues or mounting medium. These materials scatter
light to a greater extent than surrounding tissue, thus nanomaterials in a given section stand out as
bright white structures. Using this method, lung sections can be assessed through low
magnification to identify areas of CNT in tissue that would not normally be detected by other
traditional light microscopy techniques (Mercer et al., 2011).
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5.0 Statistics
Data from rodent studies were log transformed prior to analysis to meet the assumptions
of the statistical tests. Analysis of Variance (ANOVA) was done using JMP 11 with a Least
Squares Means table by Student’s t-test as a post-hoc test. Pairwise comparisons were performed
using Student’s t-test. Differences between experimental groups were considered significant with
p-values less than 0.05.
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6.0 Chapter 1: Company 1
6.1 Introduction
Manufactured MWCNT have the attention of physical chemists and scientists because of
their vast potential for industrial application. However, the occupational information regarding the
health impacts from handling these materials along their life cycle, is lacking. The first aim of this
project involved characterizing, preparing and exposing mice to an as-produced, branched
MWCNT (AP-MW) or the post-processed version, a polyurethane coated AP-MW (PC-MW).
Company 1 utilizes a unique proprietary process to create the branched MWCNT, which are then
coated with polyurethane in order to ease handling and aide in composite manufacturing. The
pulmonary toxicities of these materials remain unknown. When PC-MW are added to polymer
matrices (e.g. thermoplastics), the end result is a product with enhanced properties such as
increased strength and conductivity. This company offers a MWCNT-infused product that is
highly sought out by automotive, aviation, and construction industries.
The branched AP-MW is produced, utilized, and handled on a daily basis by facility
workers. Figure 5 shows the type of material these workers have been exposed to during normal
working hours. The material from Company 1 exists in a tangled web-like form, comprised of
several hundred entangled MWCNT as seen in personal breathing zone (PBZ) collections. A goal
of this study was to prepare the materials for animal studies that closely mimicked the PBZ samples
(Figure 5). With that in mind, toxicological responses following in vivo exposures, can be directly
correlated to human health exposures.
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Personal Breathing Zone

AP-MW in liquid medium

Figure 5: Representative TEM images of MWCNT. Images obtained from personal breathing zone
sampling from facilities (left panels) mirrored samples prepared in dispersion medium for in vivo
exposures (right panel). Facility relevant exposures are crucial when extrapolating the effects of
in vivo studies to human health relevance.

Following bulk synthesis, the branched AP-MW are packaged by facility workers and
transported to an offsite facility for post-production modifications. Company 1 selected to coat
their base material, the branched AP-MW, with a thin layer of polyurethane. This company chose
to utilize a polyurethane coating in order to reduce the dustiness associated with dry powder
handling. Polyurethane makes up 7% of the total weight of bulk material (AP-MW plus polymer)
and was accounted for so that the mass of MWCNT in each AP-MW and PC-MW sample remained
similar. Continuing along the occupational life cycle for MWCNT, the PC-MW are incorporated
into composites. These composites are manipulated by facility workers (sanding or grinding) to
generate the final product. In vivo exposures are ongoing to determine the toxicological impact of
particles generated from sanding composites containing PC-MW.
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6.2 Results
6.2.1 Characterization
Prior to in vivo exposures, extensive morphological characterization of AP-MW and PCMW was evaluated. Images obtained from PBZ were utilized to compare in vivo material
preparations (Figure 5). Material was dispersed in organic solvent and visualized with a scanning
transmission electron microscope (STEM), to verify their width distribution (Figure 6). Since the
polymer coating makes up 7 % of the weight AP-MW and PC-MW were weighed by mass and
dispersed in physiologic dosing medium, at either 1.6 mg/mL for AP-MW or 1.6 mg/930µl for
PC-MW. Each dimension was calculated through an average of n=200 nanotubes. Mean widths of
both materials were similar, approximately 16 nanometers in diameter, regardless of coating. In

AP-MW

PC-MW

Figure 6: The diameter distribution of both particles is shown (left). STEM images confirm that the
widths of both types of particles, regardless of coating, are similar.
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addition to STEM images, Table 1 shows the characterization data for each material obtained for
Company 1.

Table 1: Material characterization. Regardless of coating, mean widths were around 16.0 nm.
However, lengths between the two materials ranged from 0.22-50.9 µm.
Material
Company 1
AP-MW
Company 1
PC-MW

Mean
Length
(µm) (SD)

Length
Range
(µm) (SD)

Mean
Width
nm (SD)

Width
Range
(nm)

Zeta
Potential
(mV)

Hydrodynamic
Diameter
(nm)

2.08 (3.8)

0.22-50.9

16.5 (18.1)

6.3-216

-12.1±0.6

771±33

1.71 (1.6)

0.01-8.5

16.2 (22.0)

6.3-283

-11.9±0.5

676±8

The branched AP-MW from Company 1 is slightly longer with relatively the same mean
width as the PC-MW. Both materials obtained from Company 1 agglomerated easily in solution (11 to -12 mV). XPS also confirmed that a high degree of oxygen molecules were bound to PCMW in comparison to AP-MW (Figure 7) indicating the polyurethane coating. Endotoxin levels

C1s

C1s

AP-MW

O KLL

PC-MW

O1s

O KLL

O1s

Figure 7: PC-MW contains more oxygen than AP-MW in survey scans confirming presence
of polymer coating as indicated by the O1s peak (right). Often, polymer coatings are confirmed
by a higher oxygen content on samples of MWCNT.

were below the level of detection (data not shown) and the percent weight of metal catalyst (1.7%
iron) was similar between the AP-MW and PC-MW. Following characterization, animals were
exposed to either: physiologic dosing medium (control), 4µg, or 40 µg of AP-MW or PC-MW
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(Figure 4). The lowest dose (4µg) equates to a cumulative deposited dose of exposures seen in
evaluated workplaces to date (about seven years) (Erdely et al., 2013). In fact, this dose was
calculated based on information gained from an exposure assessment study of workers exposed to
elemental carbon at 10.6 µg/m3 over an 8 hour day. The high dose (40 µg) was chosen to
understand pathological outcomes.
6.2.2 Company 1: Pulmonary cytotoxicity, inflammatory cell influx and protein expression
Following exposure, both AP-MW and PC-MW elicited pulmonary cytotoxicity,
inflammatory cell influx and increases in mRNA expression of proinflammatory cytokines, which
was time-and dose-dependent (Figure 8-10).
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Figure 8: Cytotoxicity of AP-MW and PC-MW as measured by lactate dehydrogenase activity over
4 hr, 1, 7, 28, and 84 d post-exposure. All materials were cytotoxic however, no difference was seen
between AP-MW and PC-MW exposed groups. N=6 per group.*p < 0.05 vs DM.
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Figure 10: Bronchoalveolar
lavage protein profiling
(multiplex immunoassay RodentMAP
*
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v3.1, Myriad, RBM). Inflammatory cytokines were elevated at 1d post-exposure but resolved
by 28d. No significant
difference seen between AP-MW and PC-MW exposed groups.
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Figure 9: Polymorphonuclear leukocyte (PMN) inflammatory cell influx following exposure to APMW or PC-MW. Inflammatory cells peaked at 7d post-exposure but return to baseline by 84d. No
significant difference was seen between AP-MW and PC-MW exposure groups. PC-MW did not
increase inflammatory cell influx compared to AP-MW. N=6 per group.*p < 0.05 vs DM.

Company 1 elicited cytotoxicity, measured by lactate dehydrogenase activity, which was
significantly different from control and resolved with time. The high dose of PC-MW was not
significantly different from AP-MW (Figure 8). An increase in total cells, polymorphonuclear
leukocytes (PMN) (neutrophils and eosinophils), and alveolar macrophages (AM) was observed
in high dose exposures but no difference was observed as a result of coating over time (Figure 9,
10, 11). The influx of PMN was highest at 4 hr post-exposure and resolved by 84 d. Total cells, a
result of increased macrophages, peaked at 7 d post-exposure. The lowest dose (4 µg), regardless
of coating, did not result in any significant PMN cell influx.
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Figure 10: Total alveolar macrophages (AM) following exposure to AP-MW or PC-MW. AM from
high dose exposures peaked at 7 d and resolved over time. At 4 hr, PC-MW was significantly different
from AP-MW at similar dose. N=6 per group.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose.
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Figure 11: Total Cells following exposures to AP-MW or PC-MW. Increased total cell influx was
noticeable in the high dose exposure groups compared to sham and peaked at 7 d post-exposure. PCMW exposed groups were not significant from29
AP-MW at a similar dose, except at 4 hr post-exposure.
N=6 per group. *p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose.

Figure 12: Attempted engulfment of material by alveolar macrophages (AM) at 1 d is shown (APMW- left; PC-MW – middle and right). All particles remained as web-like aggregates in vivo.

Figure 12 shows isolated alveolar macrophages (AM) in direct contact with both AP-MW and PCMW at 1 d post-exposure. Large entanglements of AP-MW and PC-MW made it difficult for AM
engulfment. AP-MW and PC-MW continued to exist as tangled clusters following exposures
(Figure 12). It is possible that the AM interact with AP-MW and PC-MW and were unable to
separate these large bundles. Evidence of large bundles in contact with AM confirmed that these
materials remained agglomerated in vivo, which directly correlated with how these materials exist
in the workplace (Figure 5).
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These materials adversely affected inflammatory BAL proteins and gene expression in
pulmonary tissue (Figure 13 and 14). Pulmonary gene expression for inflammatory mediators,
including interleukin-6 (Il-6), were significantly different from control at 4 hr, 1 and 7 d postexposure in low and high dose AP-MW and PC-MW exposed groups (Figure 13). Relative mRNA
expression of chemokine (C-C motif) ligand 22 (Ccl22; also referred to as macrophage derived
chemokine) was significantly different in the high dose groups at 7 d post-exposure, regardless of
dose. Additionally, mRNA expression for mediators including, interleukin 1 beta (Il-1b),
chemokine (C-X-C motif) ligand 2 (Cxcl2), chemokine (C-C motif) (Ccl2), and secreted
phosphoprotein 1 (Spp1) increased expression and resolved over time (data not shown). Overall,
the relative mRNA expression of proinflammatory cytokines in PC-MW exposed groups was not
significantly different from AP-MW.
A multiplex protein profile was generated to understand the regulation of inflammatory
proteins from BALF (Figure 14). BAL proteins were analyzed with rodent multi-analytic profile
(rodent MAP v3.1, Myriad, RBM).
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Figure 13: Relative mRNA expression of AP-MW and PC-MW isolated from pulmonary tissue at 4
hr, 1, 7, 28 and 84 d post-exposure. Gene expression of Il-6 (left), and Ccl22 (right) were upregulated
with peak expression at 7 d post-exposure that returned to baseline by 84 d. N=6 per group. *p < 0.05
vs DM, #p < 0.05 vs AP-MW of similar dose.
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Figure 14: Heat map of inflammatory proteins at 1 d and 28 d post-exposure. Significant
downregulation is represented green, while red is significant of up regulation (Log2 fold
change). Time-and dose-dependent responses were observed. Additionally, polymer coating
from Company 1 had no additive effect on BAL inflammatory protein abundance.
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The rodent MAP analyzed fifty-two proteins within a sample of BALF. A time- and dosedependent response of BAL inflammatory proteins was noted. In addition, the abundance of
proinflammatory cytokines (Il-6 and Ccl22) were upregulated at the high doses of AP-MW and
PC-MW (Figure 14); these data complemented the increase of relative mRNA expression in
pulmonary tissue. Areas of red color correlate with an increase in protein abundance (log 2 fold
change) while green was indicative of down regulation, with corresponding gradients in between.
Based on the heat map, the PC-MW had similar effects on BALF protein levels when compared
to the AP-MW of Company 1, which resolved by 28 d post-exposure.
6.2.3 Histopathology observations
Tissues from mice were harvested at 1 and 84 d post-exposure for pulmonary pathology.
At 84 d post-exposure, both AP-MW and PC-MW deposited in pulmonary tissue as large
extracellular aggregates within the airways (Figure 15). In particular, the high dose of AP-MW
was found primarily within the bronchioles, entwined with resident cells. Mild neutrophilic
inflammation was seen in the bronchioles of high dose exposure groups.

Bronchiole

Figure 15. Histopathology of lung sections from exposed mice. For both materials, the majority of
particles were seen within the lumen of small bronchioles. Qualitative observation confirmed particle
location within nodular aggregates of inflammatory cells (black arrows).
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Figure 16: Representative pulmonary tissue 84d post-exposure (0.1% picosirius red staining; nuclei
counterstained with hematoxylin and eosin (H&E)). Both AP-MW (left) and PC-MW (right) were
persistent in pulmonary tissue as clusters (>20 microns) in airways. Minimal to no alveolar fibrosis
was observed.

Sirius Red staining confirmed the deposition of AP-MW and PC-MW in bronchioles at 84
d (Figure 16) and enhanced dark field microscopy validated this finding (Figure 17). The
deposition of nanotubes was clearly seen in enhanced dark field imaging as the bright white regions
within the bronchiolar space. Taken together, the images from both Sirius Red staining and
enhanced dark-field imaging show that there were little signs of a fibrotic response and most
particles deposited in the bronchioles were cleared by 84 d post-exposure. The effects of PC-MW
exposure was not significantly different compared to AP-MW exposed groups.

Figure 17: Enhanced darkfield imaging of pulmonary tissue 1d post-exposure. Initial distribution of
particle deposition in the lungs were similar between AP-MW (left) and PC-MW (right). Large dense
clumps (>20 microns) were concentrated in small airways and alveolar regions proximal to the
terminal bronchiole. (Oil immersion 100X).
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For the AP-MW exposed groups, deposited particles were observed occurred primarily in
the bronchioles and were mostly cleared by 84 d (Figure 18). The fraction of AP-MW and PCMW that deposited in alveolar space was persistent, when comparing 1 and 84 d post-exposure.
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Figure 18: Due to agglomeration, these particles were deposited mostly in the bronchioles. The
fraction in the bronchioles was cleared by 84 d post-exposure, while the fraction in alveolar regions
persisted. This graphical representation was used to show general particle distribution, quantitative
confirmation of deposition is ongoing.
6.3 Discussion
Overall, both the AP-MW and PC-MW from Company 1 induced pulmonary cytotoxicity,
increased inflammation and induced pathology. The response to these materials elicited a timeand dose-dependent response of pro-inflammatory cytokines as well as increased inflammatory
protein abundance in BAL. The PC-MW did not increase the pulmonary toxicity compared to the
base material. Pulmonary responses between both AP-MW and PC-MW groups were generally
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similar including altered pathology. The material was comprised of web-like bundles and
continued to exist in this form following exposure (Figure 5, 12, 15, 16). The results from these
exposures correlated with previous rodent models in which exposures to MWCNT caused
pulmonary inflammation, as well as a foreign body response to larger agglomerates (Ma-Hock et
al., 2009; Pauluhn et al., 2010; Mercer et al., 20113a). Qualitative assessments affirmed primary
particle deposition within the bronchioles and was mostly cleared by 84 d post-exposure.
Company 1 chose to coat their branched AP-MW with polyurethane (PC-MW) for various
reasons. This includes, increased dispersion into composites and thermoplastics as well as
increased the ease of handling. When incorporated into composites, the PC-MW have a high elastic
modulus (stiffness) which is advantageous for structural material development. Another reason is
to alter the density and organize PC-MW into a uniform network. This technique aides
compounding processes to create multifunctional thermoplastics. Most polyurethanes are
thermosetting polymers that do not melt when heated (Xiong et al., 2006; Wohlleben et al., 2013).
As a result of this mixture, the coating exploits the inherit natures of MWCNT to dissipate heat. It
has been shown that composites with 0.5-1% weight of MWCNT increased thermal conductivity
by 60% when compared to plastics alone (Zhao et al., 2011). For this reason, 3% PC-MW by
weight in composites is utilized by this particular company. More recently, the manufacturing of
thermoplastics has become extremely efficient. Smaller quantities of PC-MW are needed to
maintain the same level of thermal enhancement.
While incorporation of PC-MW has many manufacturing benefits, dry powdered AP-MW
can present adverse health effects to workers handling this material. Dahm et al. (2011), reported
that the highest amount of exposures to elemental carbon occurred during tasks of dry powder
handling at facilities manufacturing CNT. The addition of polyurethane to AP-MW provides
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additional occupational benefits as the “highly-entangled” PC-MW prevent individual MWCNTs
from being released thereby reducing the risk to workers. The potential inhalation exposure is
further diminished when smaller quantities of PC-MW are needed for composite manufacture (e.g.
thermoplastics), which reduces the amount of dry powder handling done by facility workers. The
company claims that PC-MW are easier to handle, presumably by the reduced dustiness, and this
benefits packaging processes. It is clear that PC-MW infused products can provide new
opportunities in consumer products as well as benefiting workers by reducing the potential for
occupational exposures (Wohlleben et al., 2013).
Qualitative evaluations of lung sections from AP-MW and PC-MW exposed groups
revealed adverse effects within the bronchioles (Figure 15, 16, and 17). These effects were similar
for AP-MW and PC-MW. Particle deposition was primarily confined to the upper airways. Of the
particles that were deposited in the bronchioles (AP-MW or PC-MW), most had been cleared from
pulmonary tissue by 84 d post-exposure (Figure 18). Qualitative observations of alveolar fibrosis
and collagen formation at 84 d post-exposure were absent likely due to the fact that most of this
material was deposited in the upper airways and was subsequently cleared (Figure 16 and 17).
Though the results above were qualitative, similar histopathological studies were described
previously using another type of MWCNT (Mercer et al. in 2011). Following exposure to
MWCNT 56 d post-aspiration, a significant interstitial increase of collagen fibers at high doses
(40-80 µg) was observed. A dose-responsive increase in average thickness of alveolar connective
tissue at 56 d post was noted. They concluded that a lower accumulation of MWCNT in the
alveolar interstitium resulted in a lower fibrotic related response. Based on the results from Mercer
et al. (2011), it is likely that quantitative assessments would reveal an absence of a fibrotic reaction
at later time points (28 and 84 d) due to lower alveolar deposition (Figure 18).

37

Of the particles that remained in the lung at 84 d post-exposure, several (AP-MW or PCMW) particles were contained in nodular agglomerates of inflammatory cells within the lumen of
small bronchioles (Figure 15- black arrows). No significant differences were observed when
comparing the AP-MW and PC-MW groups. Since most material was cleared from the upper
airways, the presence of granuloma formation in alveolar regions was reduced due to low material
persistence. In 2011, Mercer et al. explained that the occurrence of MWCNT in the airways at 7,
28 or 56 days post-aspiration was minimal (Mercer et al., 2011). In that same study, granulomatous
lesions in alveolar airspace accounted for only 20% of the total lung burden. At similar mass doses
of 40 µg, granulomatous lesions were relatively rare but, when present, were located near alveolar
regions close to terminal bronchioles. If deposits of MWCNT in airspaces are not effectively
cleared, a network of highly rich connective tissue can form an outgrowth in order to separate these
poorly cleared particles. This type of response is observed in lungs where insoluble and/or
particulate matter is poorly cleared (Mercer et al., 2011).
A large occupational exposure assessment study conducted in 2015 was able to quantify
both the inhalable and respirable fractions of EC in a number of facilities producing CNT (Dahm
et al., 2015). It was determined that the AP-MW from Company 1 has a respirable fraction of 3%
(Dahm et al., 2015). If the percent deposition in vivo is correlated to occupational health, only a
small fraction of that 3% would reach the alveolar region. Therefore, if a worker were exposed
during normal working hours, it is likely that most material would deposit in upper bronchioles,
with high probability of clearance according to our results. Ongoing assessments must consider
the impact of both inhalable and respirable sized particles on occupational health.
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7.0 Chapter 2: Company 2
7.1 Introduction
The second company taking part in this study purchases bulk master batches of MWCNT
from a primary manufacturer. The base material is coated with a proprietary poly(arylene
ethynylene) (PAE) polymer (Figure 2). This proprietary coating makes up 15% of the total weight
after being processed (AP-MW plus proprietary coating). Similar to Company 1, Company 2 has
introduced innovative materials to customers in aerospace, automotive and sporting equipment
industries. One of the key reasons they utilize a proprietary polymer coating is to improve the
interaction between MWCNT and resin systems. Although MWCNT are incredibly strong and
used in distinct applications, they aren’t easily incorporated into resins because of their inherent
qualities to agglomerate in solution (Pegel et al., 2008). The unique PAE coating creates a noncovalent interaction between the MWCNT. Next, the incorporation of this PC-MW into a resin
makes a stronger, more durable material. Additionally, this method effectively reduces the amount
of base material needed to reach the same endpoints of strength and durability. While many
companies use 1-5 % CNT by weight in composites, this company only utilizes 0.15%.
PBZ images obtained from facilities handling this AP-MW shows MWCNT in tight
bundles and clusters. Preparations of AP-MW closely mimics workplace exposures (Figure 19).
Each exposure was identical to the methods carried out for Company 1 (Figure 3 and 4). It was
hypothesized that PC-MW would alter toxicity compared to AP-MW, in vivo. Following time-and
dose-dependent exposures, it was verified that exposures to PC-MW does in fact alter pulmonary
toxicity in comparison to AP-MW in vivo.
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7.2 Results
7.2.1 Characterization
Representative PBZ TEM images of material obtained from Company 2 detail
characteristics of this material. When in dispersion medium, this material tends to form small
clusters around 500 nm (Figure 19). In addition, both particles (AP-MW or PC-MW) remain
similar in their diameter distribution (16 nm) and STEM images confirmed that polymer coating
does not increase particle diameter (Figure 20). AP-MW are longer in length and higher in
hydrodynamic diameter compared to PC-MW (Table 2). The surface chemistry of the PC-MW is
different than AP-MW and analysis by XPS confirms a higher amount of oxygen bound to PCMW compared to AP-MW, confirming the polymer coating (Figure 21). The catalytic metals were
similar (2% aluminum and 1.7% iron) and endotoxin was below the level of detection (data not
shown).
Personal Breathing Zone

AP-MW in liquid medium

Figure 19: Representative TEM images of MWCNT. Images obtained from personal breathing zone
sampling from facilities (left panel) mirrored samples prepared in dispersion media for in vivo
exposures (right panel). Relevant facility exposures are crucial when extrapolating the effects of in
vivo studies to human health relevance.
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AP-MW

PC-MW

Figure 20: The diameter distribution of both particles is shown (left). STEM images confirm that both
types of particles are generally similar (right).

C1s
AP-MW

C1s
PC-MW
O1s

O KLL

O1s

O KLL

Figure 21: X-ray photoelectron microscopy detailed the surface chemistry of AP-MW and PC-MW. According
to peaks, PC-MW contained more oxygen than AP-MW in survey scans confirming coating.
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Table 2: Particle characterization for AP-MW and PC-MW. Mean widths of all materials remain
similar, regardless of polymer coatings while hydrodynamic diameter is altered in PC-MW.
Material

Company 2
AP-MW
Company 2
PC-MW

Mean
Length
(µm)
(SD)
1.28
(1.1)
0.77
(0.4)

Length
Range
(µm) (SD)
0.10-8.51
0.15-2.44

Mean
Width
nm (SD)
25.5
(34.9)
15.2
(3.50)

Width
Range
(nm)

Zeta
Potential
(mV)

Hydrodynamic Diameter
(nm)

7.8-275

-11.1±0.6

608±30

8.6-32.0

-10.7±0.4

360±12

7.2.2 Cytotoxicity, pulmonary inflammation and protein analysis
Both materials were cytotoxic and induced an inflammatory cell influx compared to control
groups (Figure 22-25). Cytotoxicity was attenuated following PC-MW exposure and resolved over
time (Figure 22). No significant effect was observed for the low dose groups. Total PMN influx
was increased at 4 hr, and 1 d post-exposure, and both high dose groups were significantly different
from sham. By day 7, only the AP-MW exposed groups was significant. The high dose AP-MW
groups at 4 hr post-exposure, was significantly different than the PC-MW at the same dose (Figure
23). Likewise, total cell and alveolar macrophage influx were attenuated in the high dose PC-MW
groups at 7 and 84 d post-exposure (Figure 24 and 25). Alveolar macrophages were observed
engulfing particles of AP-MW and PC-MW (Figure 26).
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Figure 22: Cytotoxicity of AP-MW and PC-MW as measured by lactate dehydrogenase
activity over 4 hr, 1d, 7d, 28, and 84d post-exposure. All materials were cytotoxic; however,
differences are seen in PC-MW exposed groups compared to similar dose of AP-MW. N=6 per
group.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose.
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Figure 23: Polymorphonuclear leukocyte (PMN) Inflammatory cell influx following exposure
to AP-MW or PC-MW. Inflammatory cells peaked at 7d post-exposure to PC-MW, but return
to baseline by 84d. A significant difference was seen between AP-MW and PC-MW exposure
groups at 4 hr post-exposure. PC-MW did not increase inflammatory cell influx compared to
AP-MW. N=6 per group.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose.
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Figure 24: Total alveolar macrophages following exposure to AP-MW and PC-MW. High
dose exposures caused the greatest increase in alveolar macrophages at 7 d with significance
in AP-MW exposed groups. N=6 per group.*p < 0.05 vs DM.
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Figure 25: Total pulmonary cell influx following exposures to AP-MW and PC-MW over
time. As expected, high dose exposure groups elicited the greatest responses at 7 d postexposure and PC-MW was significantly different than AP-MW at similar dose at this time
point.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose.
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MRNA for inflammatory cytokines (Il-6 and Ccl22) were significantly increased from
control in the high dose AP-MW and PC-MW exposed groups (Figure 27). Similar results were
found for relative mRNA expression of Il-1b, Cxcl2, Ccl2 and Spp1 (data not shown). At 1 and 7
d post-exposure, relative mRNA expression for these cytokines were attenuated in the high dose
PC-MW groups compared to AP-MW (Figure 27). In addition to relative mRNA expression, BAL
inflammatory protein levels were elevated at 1 d post-exposure with attenuation by 28 d postexposure. At 1 d post-exposure, pro-inflammatory proteins, in general, associated with PC-MW
exposure were lower compared to the AP-MW, at the same dose (Figure 28). Together, relative
mRNA expression was time-and dose-dependent and complementary to BAL protein regulation
(Figure 27 and 28).

Figure 26: Alveolar macropages (AM) successfully engulfing AP-MW and PC-MW. Often
particles were seen as dense clumps within AM (AP-MW-left and middle; PC-MW- right).
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Figure 27: Pulmonary inflammatory mRNA expression of interleukin-6 (Il-6) and chemokine (C-C
motif) ligand 22 (Ccl22). Generally, Il-6 was increased relative to sham and resolved over time.
Significant attenuation of Il-6 was observed in PC-MW exposed groups compared to similar dose of
AP-MW (left). Relative expression of Ccl22 was greatest in high dose exposures, while PC-MW
exposed groups were significantly different at 1 and 7 d post-exposure (right). N=6 per group. *p <
0.05 vs DM, #p < 0.05 vs AP-MW of similar dose.
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Figure 28: BAL inflammatory protein regulation at 1 and 28 d post-exposure to AP-MW and
PC-MW. Time-and dose-dependent responses were observed for all materials. Overall, BAL
inflammatory proteins were altered in PC-MW groups.
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Following exposure, inflammation, granuloma formation and particle distribution were
evaluated in pulmonary tissue samples. Clusters of AP-MW and PC-MW were located around
terminal bronchioles (Figure 29). Alveolar fibrosis was qualitatively analyzed and no pronounced
increase was observed (Figure 30). At 84 d post-exposure, small clumps of AP-MW were found
in macrophages in regions of alveolar airspace.

Figure 29: Qualitative pathological evaluation showed majority of AP-MW (left) near terminal
bronchioles. In contrast, PC-MW (right) were seen as large aggregates and do not elicit the
same pathological consequences consistent with AP-MW exposed lungs.

Figure 30: Representative pulmonary tissue 84d post-exposure (0.1% picosirius red staining;
nuclei counterstained with hematoxylin and eosin (H&E)). Images of collagen fibers in APMW (left) and PC-MW (right) exposed lungs at 84 d post-exposure. Sections of alveolar
regions laden with AP-MW (left) and minimal collagen fiber formation.
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Figure 31: Enhanced darkfield microscopy of AP-MW at 24 hr (left) and 84 d (right) postexposure. Large particles were seen deposited at bronchiole to alveolar duct junctions (left)
while 84 d post-exposure particles were viewed inside alveolar macrophages (right) (oil
immersion 100X).
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Figure 32: Particles mostly deposited both the bronchiole and alveolar regions. Particles that
remained at 84 d exhibited persistence in alveolar regions. The fraction deposited in the
bronchiolar regions were effectively cleared.
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Mild inflammation of neutrophils was associated around particle deposits. In contrast to AP-MW,
fewer particles of PC-MW were present within alveolar macrophages. Some of the material existed
as extracellular aggregates and lacked associated inflammatory cells (Figure 29). Granuloma
formation was apparent in AP-MW groups at 84 d (Figure 29 - left) but absent in PC-MW groups
(Figure 29 – right). High dose exposures were associated with particle deposition around terminal
bronchioles and alveolar ducts as seen in EDM (Figure 31). Minimal to no inflammation was noted
and particle abundance of PC-MW was significantly less than the AP-MW.
Biodistribution of particles was assessed to understand deposition in the bronchiole and
alveolar regions. Depositions of both particles were observed in the bronchiole and alveolar space.
Of the total percent deposited at 1 d post-exposure, the high dose of AP-MW and PC-MW mainly
deposited in alveolar regions (both 75%). At 84 d post-exposure, the largest fraction of the total
deposition remained in the alveolar space for both AP-MW and PC-MW. Particle clearance
occurred in the bronchioles while the remaining percent deposition in alveolar regions persisted
over time (Figure 32).
7.3 Discussion
A purchased bulk supply of MWCNT was coated with a proprietary PAE polymer in order
to enhance dispersion for composite material application. Overall, exposures to AP-MW and PCMW induced time- and dose-dependent responses of pulmonary cytotoxicity, inflammation, and
increased inflammatory protein abundance in BAL compared to sham treated mice. Based on
results, the pulmonary toxicity of PC-MW exposed groups was attenuated in comparison to APMW treated groups. Primary particle deposition occurred within the alveolar regions which
persisted at 84 d post-exposure. Qualitative observations of pathology indicated AP-MW exposed
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groups exhibit signs of granuloma formation, whereas pulmonary tissue from PC-MW exposed
groups do not. This was consistent with the hypothesis that PC-MW decreases toxicity compared
to the respective AP-MW (Figure 29).
Company 2 recognized the benefits of using MWCNT in composite material because of
their high mechanical strength and high electrical and thermal conductivity and was prepared to
expand their division of composite materials. However, their difficult manipulation into host
matrices imposed enormous limitations to their use in large-scale material production. Engineers
and polymer scientists developed, a surface treatment and functionalization protocol to improve
dispersion and interaction of MWCNT in various matrices. This surface treatment is their
proprietary PAE polymer coating. This coating is a non-covalent, non-wrapping approach in which
rigid conjugated PAE polymers adhere to the surface of the MWCNT. Side chains are added to
this backbone for enhanced compatibility, increased adhesions to host matrices, and limited
MWCNT induced aggregation. The major interaction between the PAE backbone and nanotube
surface creates a stabilizing energy and eases their incorporation into a large array of diverse
matrices for downstream products.
The toxicological evaluation of the base AP-MW was similar to previous results that
demonstrated an increase in the inflammatory potential of MWCNT following pulmonary
exposures in vivo (Warheit et al., 2004; Shvedova et al., 2005; Mercer et al., 2011). Qualitative
observations of lungs exposed to the high dose AP-MW, show particle clearance, by 84 d postexposure. AP-MW remaining in the lung at 84 days post-exposure were present in small
granulomas at terminal bronchioles, or within alveolar macrophages (Figure 26, 29-31). As these
are qualitative observations, numerous studies have discussed an increase in granuloma formation
following similar doses of MWCNT in vivo. In addition, Mercer et al. (2011) reported the frequent
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incidence of highly loaded alveolar macrophages in MWCNT-exposed lungs, which was
consistent with our findings (Figure 26, 29-31).
Tabet et al. (2011) showed that a polystyrene-coated CNT was protective against
pulmonary toxicity. In conjunction with their results, we were able to conclude that PC-MW
induced reduced effects on cytotoxicity, inflammatory cell recruitment, and inflammatory protein
production (Figure 22-25; 27 and 28). Enhanced darkfield imaging and qualitative assessment of
pulmonary deposition confirmed primary particle deposition within the alveolar regions for both
AP-MW and PC-MW exposed groups and particles persisted at 84 d post-exposure (Figure 31 and
32). However, granuloma formation was absent in the high dose PC-MW exposed groups. In fact,
PC-MW particles were qualitatively reported as large aggregates located at terminal bronchioles
with minimal inflammation (Figure 29). Several mechanisms may explain these results and were
further supported by Tabet et al. (2011). First, the coated MWCNT contained 15% polymer by
weight and may have affected the delivered dose by altering the density of total nanotube material.
Therefore, the lack of a granulatomas response was simply due to a reduction in total particle load
to the lung. Ongoing assessments are being performed to confirm that a reduction in MWCNT
mass was not responsible for absent pathology and inflammation. Pauluhn et al. (2010) reported
that the potential of MWCNT particles to cause reactions within the lung were dependent upon
particle size, composition, and retained dose, which lends support to the lack of pathological
responses in groups exposed to PC-MW. Second, perhaps the PC-MW were more hydrophobic
than their counterpart, AP-MW, which could reduce cell adherence and explain the lack of
inflammation surrounding large aggregates (Figure 32) (Tabet et al., 2011). A combination of these
factors may contribute to the altered responses observed in the PC-MW exposed groups and
ongoing studies are evaluating this phenomena. The primary aim for utilizing a proprietary PAE
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coated MWCNT was to improve dispersion into epoxy matrices, and not necessarily reduce worker
exposure. However, based on the results of this study, the reduction in pulmonary toxicity
associated with PC-MW may improve the occupational safety of workers handling these coated
tubes.
Overall, it is clear that the proprietary PAE polymer reduced pulmonary toxicity in
comparison to AP-MW exposed groups in vivo. Ongoing quantitative assessments are underway
to confirm absent granuloma formation and reduced inflammation in pulmonary tissue of the PCMW exposed groups. Additionally, experiments are in progress to explain the underlying
biochemical mechanism for such large particle aggregation and inflammatory response (Figure
29).
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8.0 General Discussion
The main findings from this study support the hypothesis that pulmonary exposures to PCMW cause varying degrees of pulmonary toxicity when compared to the base AP-MW. In neither
instance did the polymer coating increase the toxicity of MWCNT. In fact, inflammation and
adverse histopathology were attenuated by the PAE coating used by Company 2. There was
remarkable consistency between PBZ collections, in vivo dosing preparations, and material
observations in alveolar macrophages isolated from BALF (Figure 5, 12, 15, 19, 26, and 29),
suggesting that our general toxicity finding can be reasonably extrapolated to human health
outcomes.
The BAL inflammatory cell and protein results detailed in this study qualitatively agree
with other MWCNT studies. Porter et al. (2010) reported a dose response to increased
polymorphonuclear leukocytes (PMN) following MWCNT exposures in vivo at similar doses (40
µg). Pro-inflammatory cyotkines were increased at high dose exposures, and this was in agreement
with previous studies involving CNT exposure (Erdely et al., 2009, 2011; Ma-Hock et al., 2013).
However, different types polymer coatings, such as the proprietary coating (PAE) from Company
2, appears to attenuate inflammation and developing pathology.
It should be noted that the PAE coating from Company 2 can have any number of side
chain combinations added to the backbone which makes predicting the pulmonary toxicity of other
PAE polymer-coated MWCNT difficult. From a dosimetry perspective, the low dose caused some
inflammation that was acute, while the high dose caused significant inflammation that resolved
with altered histopathology. The low dose was extrapolated to represent 7.6 years and the high
dose, 76 years, of an average exposure to workers in a U.S. facility (Erdely et al., 2013). The first
study of humans exposed to MWCNT, from a single facility, measured increased markers of
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oxidative stress in enhaled breath condensates (Lee et al., 2015). These workers had a similar
exposure compared to U.S. facilities with an average time of employment of four years. The
general results (cytotoxicity, pulmonary inflammation) of this current study was consistent with
past outcomes of inflammation in vivo and extrapolations to the general workforce.
How does the polymer coating from company 2 attenuate toxicity? It was observed from
the histopathology that this particular material, once coated, tends to form a few large
agglomerations in the conducting airways, unlike the uncoated counterpart. These large
agglomerates seemed to be devoid of surrounding inflammatory cells. The formation of
agglomerates would theoretically reduce the amount taken up by macrophages. This assumption
would be consistent with a previous study showing reduced macrophage uptake of PMMA-coated
MWCNT (Tabot et al., 2011). The reduced uptake by macrophages and resultant lower cell
accumulation result in the observed attenuated inflammatory response seen in both this study and
by Tabot et al., 2013. Also, the lack of inflammatory cells surrounding the agglomerates and
absence of granulomas, would suggest a decreased surface activity for PAE-coated MWCNT.
Another potential contributing factor was the general appearance of reduced deposition. This is
likely a product of the large agglomerates (difficult to know how much CNT was contained) but
may also be a product of altered density of the coated material. Ongoing studies are looking at
macrophage accumulation and whether the coating affected the density of the material.
The results of this in vivo study closely related to findings of field assessment studies of
facilities manufacturing and handling CNT. Preparations of MWCNT that mimic workplace
exposures are paramount for occupationally-relevant interpretations (Figure 5 and 19). Our
nanomaterial preparation and degree of dispersion mimics PBZ measurements from exposure
assessment studies conducted in the U.S. (Dahm et al., 2015). Most biological studies take

55

considerable measures to disperse tangled MWCNT to produce a respirable material. The question
can be raised whether the generated material is representative of human exposures or if the
toxicological findings are the product of a different material structure size. To date, our research
group is the only one to integrate exposure and toxicity assessments. This integration provides
human health context to the toxicological outcomes.
Despite the potential attenuation of toxicity due to some polymer coatings of MWCNT
(this study and Tabet et al., 2011), caution should be taken in workplaces that handle large
quantities of AP-MW and PC-MW. The scientific community relies heavily on animal models to
evaluate results from exposures and assess their impact on the working population, as
epidemiological studies in the past had not been conducted (Birch et al., 2011). Future
toxicological studies involving PC-MW must incorporate extensive chemical characterizations,
paired with in vivo and in vitro studies, in order to make predictions of their impact on human
health (Oberdorster et al. 2016; Simeonova et al., 2009). From the results of this study and other
toxicological evaluations in vivo, pulmonary exposures to PC-MW have the potential to induce
significant toxicity and should not be assumed as non-toxic.
An area of emphasis not currently addressed was the toxicologic impact of PC-MW
following their addition into thermoplastics or composite material. Compared to composite
material alone, these nano-enabled composites are more resistant to strain and have greater tensile
strength (Cena et al., 2011). This study has addressed the toxicity of CNT in the first two stages
along their life cycle from AP-MW synthesis, and post-processing (e.g. polymer coating).
However, the next step of manufacturing involves incorporating the PC-MW into a polymer
matrix (e.g. epoxy resin) and mechanically processing the PC-MW embedded composites. These
processing steps include sanding or grinding activites, another task of manufacturing with risk of
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inhalation exposure to particulates (Dahm et al., 2015). However, it remains unknown if the
particulates generated as a result of sanding the PC-MW nanocomposites pose a toxicological risk
to workers manipulating these materials. Additionally, it is unknown how different types of
polymer coatings, like the ones addressed here, affect particulate generation. Ongoing studies are
characterizing the aerosol generated following an industrial sanding process and complementary
in vivo studies are addressing the toxicological impact of the respirable fraction generated from
composites containing the PC-MW. To date, there has been no indication that free PC-MW are
released following sanding of the composites. In support, previous studies that processed CNTnanocomposites reported that respirable sized particles are generated but generally lack the
presence of free nanoparticles (Cena et al., 2011). Also, it was concluded the probability of adverse
health effects due to the inhalation of free PC-MW from sanded particulates generated from
composites remains extremely low (Wohlleben et al., 2011). To date, no studies have shown
enhanced toxicity from particulates collected from CNT-enabled composites compared to particles
collected from the base composite with no CNT added.
The issue of health and wellness is not new to manufacturers of engineered nanomaterials,
many of whom, have introduced engineering controls to reduce worker exposure. There are tasks
within any workforce where individuals face a host of challenges that could result in reduced
stamina, flexibility and strength. Considering all the variables to maintain optimal worker health,
the easiest to control is exposure by preventative measures such as ventilation, filtration and
enclosure. By understanding the toxicity of CNT along their life cycle, from AP-MW to PC-MW,
companies like evaluated here, can use this information to establish protocols that reduce worker
exposure and toxicity, while continuing to make advancements in nano-enabled products.
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